Skip to main content

Wedbush Raises Price Target on Apogee Therapeutics (APGE)

Wedbush has increased its price target for Apogee Therapeutics, indicating positive market sentiment.

by Editorial Staff|Mar 10, 2026|1 MIN READ|WORLD

Summary

  • Summary pending editorial review.

Key Facts

Fact Value
Firm Wedbush
Company Apogee Therapeutics (APGE)
Date 2026-03-10

Sources

Updates

Update at 15:46 UTC on 2026-03-13

Yahoo Finance reported UBS has increased the price target for EchoStar (SATS) stock, indicating positive market sentiment.

Sources: Yahoo Finance